Yuan, X., Huang, Y., Guo, Q., Xie, Y., Xu, N., Jin, X., Tong, J., Liang, Y., Qian, W. (2025). Orelabrutinib, sintilimab, and temozolomide (OST) in relapsed/refractory primary central nervous system lymphoma. Blood. https://doi.org/10.1182/blood-2025-5461